ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11441 | Rec_0011448 | Unnamed |
RGRKVVRRVV |
synthetic construct [Synthetic] |
Antimicrobial |
- |
- | - |
- | US 2011/0039760 A1 |
YES |
| 11442 | Rec_0011449 | BCAS-16 |
KNQYGRIRVLQRFNQR |
Glycine max [Plant] |
Hemolytic |
40% hemolysis of hRBC at 50 microM |
50 μM | Hemolysis |
28459130 | - |
YES |
| 11443 | Rec_0011450 | Defensin-A (21-30) |
AAHCLAIGRK |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Salmonella typhimurium KCTC 1926 |
7.5 μM | MIC |
24393527 | - |
YES |
| 11444 | Rec_0011451 | Putative defensin-like protein 33 (Plant defensin) |
QNPRGRKCEDPNGVDQKAKCYIYCNEQGFLGGSCQGYTNHYMCECYVG |
Arabidopsis thaliana [Plant] |
Antimicrobial, Antifungal |
- |
- | - |
15955924 | - |
NO |
| 11445 | Rec_0011452 | Papiliocin (1-22)[W2A] |
RAKIFKKIEKVGRNVRDGIIKA |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli CCARM 1229 |
2 μM | MIC |
26156126 | - |
YES |
| 11446 | Rec_0011453 | Sph30-38 |
VGRIHRHLK |
Scylla paramamosain [Animal] |
Antimicrobial, Antibacterial, Antifungal, Anti-Gram-positive, Anti-Gram-negative |
Aeromonas hydrophila subsp. hydrophila |
48 μM | MIC |
28600196 | - |
YES |
| 11447 | Rec_0011454 | Bradykinin-potentiating peptide 6a |
QSWPGP |
Bothrops jararaca [Animal] |
Hormone, Endocrine, Vasoactive, Vasodilator, Cardiovascular, Enzyme modulation, Ion channel modulation, Receptor modulation, ACE inhibitory |
angiotensin-converting enzyme |
- | - |
11994001;21185808 | - |
YES |
| 11448 | Rec_0011455 | Techylectin-5B |
DVHHHAACSTVCSLKGILDSVSDLTDLAKERLATLQNPICSKDKAFYMETYTNVTQNKAEKNGLPINCATVYQQGNRTSGIYMIWPLFLNHPISVFCDMETAGGGWTVIQRRGDFGQPIQNFYQTWESYKNGFGNLTKEFWLGNDIIFVLTNQDSVVLRVDLEDFEGGRRYAEAVEFLVRSEIELYKMSFKTYKGDAGDSLSQHNNMPFTTKDRDNDKWEKNCAEAYKGGWWYNACHHSNLNGMYLRGPHEESAVGVNWYQWRGHNYSLKVSEMKIRPIIFVPGEGLPK |
Tachypleus tridentatus [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Staphylococcus aureus 209P |
26.8 μg/mL | MIC |
10468566 | - |
YES |
| 11449 | Rec_0011456 | Glycoprotein hormones alpha chain |
FPDGEFTTQDCPECKLKKNKYFSKLGVPIYQCMGCCFSRAYPTPARSKKTMLVPKNITSEATCCVAKAFIRVTLMGNIRLENHTQCYCSTCYHHKI |
Equus asinus [Animal] |
Hormone, Endocrine, Reproductive regulator, Receptor modulation |
- |
- | - |
8672238 | - |
NO |
| 11450 | Rec_0011457 | Unnamed |
HPPPEEKLRDDRSLRSNSSVNLLDFPSVSIVALNKNSKQISRKEAEKKRSSKKEASMKKVARPRTPLSAPCVTTRDSCKPPAPACCDPCASCQCRFFRSACSCRVLSLNC |
not reported [other] |
Metabolic |
- |
- | - |
39514414 | - |
NO |
| 11451 | Rec_0011458 | Lysozyme [001-003] |
KVF |
Gallus gallus [Animal] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-I converting enzyme |
14.0 μM | IC50 |
- | - |
YES |
| 11452 | Rec_0011459 | Trypsin inhibitor |
EDEECAKTDQICPPNAPNYCCSGSCVPHPRLRIFVCA |
Mirabilis jalapa [Plant] |
Enzyme inhibitory |
- |
- | - |
17481678 | - |
YES |
| 11453 | Rec_0011460 | DNA-directed DNA polymerase |
MSDEMLFEFVEEKTLDISREDADIEYMTNALYGREGMYPHIDQKGILTCPGGMTIGNSNKECIEKGLPQWIPDMKRKDLGYPHDNKTTSMLMRNDLVKRRAGLTNSIPGFRNLEPTVRRALLDVSYNANISNSSKSFPNLKRDLNIYMKSQDDKDLAIAMRNILDVVKISDTKNAGFSKGLAKRRASSYNNVARAVGFPPITRIKGNADGSIGYHFDGSHRAEMNIPAPVNKRFHKDYGYFANETRTDQSGEWVLGMGAN |
Chromatiaceae bacterium [Bacterium] |
Antimicrobial, Bacteriolytic, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 11454 | Rec_0011461 | Unnamed |
VDQDLVGWPAPQGSRSLT |
not reported [other] |
Anti-inflammatory, Immunomodulatory |
- |
- | - |
34478499 | - |
NO |
| 11455 | Rec_0011462 | IBP02V1 |
ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL |
synthetic construct [Synthetic] |
Antimicrobial, Anti-SARS-CoV-2 |
SARS-CoV-2; cell-cell fusion system |
0.0011±0.0001 μM | IC50 |
34344868 | - |
YES |
| 11456 | Rec_0011463 | Mastoparan-A |
IKWKAILDAVKKVI |
Vespa analis [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli JM109 |
8 μg/mL | MBC |
21884742 | - |
YES |
| 11457 | Rec_0011464 | Wollamide B [L2I] |
WILVNX |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Human hepatocellular carcinoma HepG2 |
100 μM | IC50 |
28423019 | - |
YES |
| 11458 | Rec_0011465 | Unnamed |
MLKFAVVALLVAAVMAEDFKFQDCGHSEVKHLELSGCSGSHCVIHKGKDFMMTADLVSNQDTKKVHVKIVADVGGLKLPIPGVDEDGCKHIKCPLTKGEEAKFTYSMNIPKLIPNIKAHVIATLSGDHGVMACVNVDGEVKN |
not reported [other] |
Immunomodulatory, Allergenicity |
allergenicity model |
- | - |
- | - |
NO |
| 11459 | Rec_0011466 | AMP 1A analogs6 |
GFXGXKXGXFXGXGKXKKKK |
Synthetic construct [Synthetic] |
Antimicrobial, Anticancer |
Tumor cells: RL |
6.7 μM | IC50 |
27387357 | - |
YES |
| 11460 | Rec_0011467 | GAPRFL-amide |
GAPRFL |
Aplysia californica [Animal] |
Neuropeptide, Neuromodulator |
- |
- | - |
10531464 | - |
NO |